UAE to become regional pharmaceutical hub with Pharmax-Acino partnership

By Shilpa Annie Joseph, Desk Reporter
  • Follow author on
Pharmax
Representational Image

UAE-based leading pharma Pharmax Pharmaceuticals has entered into a strategic partnership with Swiss drug company Acino in a move towards making the Emirates a regional pharmaceutical manufacturing hub.

Dr. Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licenses at the UAE’s Ministry of Health and Prevention (MOHAP) said, “This partnership between Acino and Pharmax is in line with the UAE’s strategy aimed at bringing high-quality medicines in the country, and strengthening our position as a healthcare pioneer in the region, especially in the production of innovative and similar medicines in local factories in the United Arab Emirates– in partnership with international pharmaceutical companies.”

Furthermore, Acino will strengthen its commitment to the MOHAP’s aim of improved access to high-quality vital medications for patients and healthcare providers in collaboration with Pharmax.

Madhukar Tanna
Madhukar Tanna
CEO – Pharmax

“The partnership between Pharmax Pharmaceuticals and Acino is one that is multidimensional and synergistic. It will enable both companies to enhance access to affordable high-quality medicines here in UAE and the region. Both organizations have worked very closely in a time-bound manner to realize this partnership, and are constantly guided by MOHAP’s vision of bringing and developing technology locally and boosting domestic production. I look forward to seeing both organizations build on a strong foundation to pursue our shared objectives.”

The deal will cover the license, production, and distribution of specific Acino products throughout the Middle East and Africa, based on patient needs. These include gastroenterology, pain relief, and the cardiovascular system, which is around half of Acino’s UAE portfolio. The first locally manufactured product is expected to be available in the UAE market later this year.

“Acino is committed to advancing the development of healthcare across the UAE and the wider region by accelerating access to high-quality medicines that patients and governments can trust and value,” noted Dr. Andrew Bird, General Manager and Head of Region, Middle East, Turkey, and Africa, Acino.

Related: UAE becomes the world’s second country that uses Lumakras to beat lung cancer


YOU MAY LIKE